PHASE-II TRIAL OF MITOXANTRONE IN REFRACTORY ACUTE-LEUKEMIA

被引:0
|
作者
ESTEY, EH
KEATING, MJ
MCCREDIE, KB
BODEY, GP
FREIREICH, EJ
机构
来源
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 04期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:389 / 390
页数:2
相关论文
共 50 条
  • [31] PHASE-II EVALUATION OF ACLARUBICIN IN REFRACTORY ADULT ACUTE-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    DABICH, L
    BULL, FE
    BELTRAN, G
    ATHENS, JW
    COLTMAN, CA
    WEICK, JK
    VANSLYCK, EJ
    AMARE, M
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 967 - 969
  • [32] PHASE-II STUDY OF 4'EPI-DOXORUBICIN IN ACUTE-LEUKEMIA
    ESTEY, E
    KEATING, M
    MCCREDIE, K
    BODEY, G
    WALTERS, R
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 118 - 118
  • [33] ARE 2 COURSES OF CHEMOTHERAPY REQUIRED IN PHASE-II TRIALS IN ACUTE-LEUKEMIA
    ARLIN, ZA
    LEUKEMIA, 1987, 1 (10) : 734 - 735
  • [34] A PHASE I-II TRIAL OF 4'-DEOXYDOXORUBICIN (ESORUBICIN) IN REFRACTORY OR RELAPSED ACUTE-LEUKEMIA
    DUTCHER, JP
    RIGGS, CE
    STRAUMAN, JJ
    LINK, B
    WIERNIK, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 424 - 428
  • [35] MITOXANTRONE IN THE TREATMENT OF ACUTE-LEUKEMIA
    VOROBIOF, DA
    FALKSON, G
    COCCIAPORTUGAL, MA
    TERBLANCHE, APS
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (04) : 383 - 388
  • [36] ACLARUBICIN IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA REFRACTORY TO TREATMENT WITH DAUNORUBICIN AND CYTARABINE - A PHASE-II TRIAL
    PEDERSENBJERGAARD, J
    BRINCKER, H
    ELLEGAARD, J
    DRIVSHOLM, A
    FREUND, L
    JENSEN, KB
    JENSEN, MK
    NISSEN, NI
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1233 - 1238
  • [37] PHASE-II STUDY OF TREATMENT OF REFRACTORY ACUTE-LEUKEMIA WITH INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND AMSACRINE
    JEHN, U
    HEINEMANN, V
    ANNALS OF HEMATOLOGY, 1993, 66 (03) : 131 - 134
  • [38] A PHASE-II TRIAL OF HIGH-DOSE ARA-C AND MITOXANTRONE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA (ANLL)
    FUHR, HG
    LINDEMANN, A
    HERRMANN, F
    HIDDEMANN, W
    MERTELSMANN, R
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 121 - 121
  • [39] PHASE-II TRIAL OF MITOXANTRONE IN ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    GRAHAM, ML
    ESTRADA, J
    RAGAB, AH
    STARLING, KA
    ROSEN, D
    WILKERSON, RW
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) : 263 - 267
  • [40] A PEDIATRIC-ONCOLOGY-GROUP (POG) PHASE-II TRIAL OF MITOXANTRONE, ETOPOSIDE AND CYCLOSPORINE A (MEC) THERAPY FOR RELAPSED AND REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
    DAHL, G
    DUNUSSI, K
    MOGUL, M
    BROPHY, N
    LOWE, K
    GRIER, H
    SIKIC, B
    WEINSTEIN, H
    ARCECI, R
    BLOOD, 1993, 82 (10) : A195 - A195